Consumer Edge

Consumer Edge has turned a broad set of transaction panels into the most transparent AI product in this segment. Its US card data covers more than 100 million cards back to 2016, alongside SKU-level receipts, web traffic, European transactions and, since the Earnest Analytics acquisition in April 2025, healthcare data. Cosmos Agent (April 2026) answers spending questions in plain English and shows the SQL, sources and method behind every answer; on 15 October 2026 the same data reached Claude and ChatGPT through CE Cosmos MCP. Research Signal, launched in June, pairs spend data with analyst forecasts and a back test over more than eight quarters.

Enterprise evidence is the gap. We did not locate SOC 2 or ISO 27001, a trust or security page, SSO or audit-log documentation, an AI-use or no-training statement, or a description of consent and MNPI screening beyond anonymisation. The model behind Cosmos is not named, the back test is company-reported, no quantified client case was located, and pricing is not published.

We initiate at 6.10, Emerging, with an Improving outlook. Product Capability (7.17) and Workflow Fit (6.92) lead its profile; Enterprise Readiness, at 4.57, is the weakest dimension. Published assurance and AI terms would move the score most.

Strengths

• Panel breadth. More than 100 million US cards, SKU-level receipts, web traffic, European transactions and healthcare claims and hospital purchases.
• Transparent agent. Every Cosmos Agent answer shows the SQL, data sources and methodology, and can be cross-checked from the MCP connection.
• AI-assistant delivery. CE Cosmos MCP brings the data into Claude and ChatGPT and lets users blend it with their own data.
• Investor packaging. Research Signal combines spend-based forecasts, consensus, a back-tested record and ticker-specific risks in one report.
• Quant delivery. Snowflake, S3, BigQuery and a row-level direct feed with daily updates.
• Release cadence. Five AI and data launches in twelve months, from the October 2025 chat beta to Cosmos MCP.

Cautions

• Assurance. We did not locate SOC 2, ISO 27001, SSO, audit-log documentation or a trust page.
• AI terms. The model behind Cosmos and the terms for client data are not published.
• Provenance. Data are described as anonymised; consent, MNPI and personal-data screening are not documented.
• Evidence. The Research Signal back test is company-reported; no independent study or quantified client case was located.
• Point-in-time. Panel-change and restatement handling are not documented.
• Pricing. Not published; a free sample is offered but no trial was located.
• Integration. Three acquisitions since 2021, the latest in April 2025, are still being combined.